A number of pharmaceutical companies in the US have been forced to settle claims related to a deadly opioid epidemic. Experts have linked the crisis to prescription practices in the country. In the second of this two-part series, William Denselow looks at efforts to change those practices and how settlement funds could be used to help people struggling with addiction. Watch the full video here.